Book Navigation
x

We are sorry, but signing in with LinkedIn is not possible at this time.

 

How to disseminate reviews with network meta-analysis (NMA) *NMA Learning Live Webinar series*

Cochrane presents the next webinar in its Learning Live series with the NMA Learning Live Webinar: "How to disseminate reviews with network meta-analysis (NMA)". A recording from this webinar is now available. Downloading, copying, reusing or distributing these files is not permissible.

Cochrane presents the sixth webinar in its NMA Learning Live Webinar series, which will discuss challenges and strategies for making reviews with network meta-analysis (NMA) more accessible to those who need them to make health decisions.

The webinar is intended for anyone planning or undertaking a systematic review with NMA, as well as people who want to share the results of this type of review with Cochrane’s target audiences. It will be of interest to anyone interested in making evidence more accessible, including review author teams, CRG editors, methodologists, clinicians, Geographic Groups and Fields. The focus will be on psychiatric disorders, but the methodology and the approach can be extended to any other field of medicine and psychology.

The format of the webinar will be a presentation including examples from the scientific literature, followed by a Q&A session.

Recording of the webinar:-

How to disseminate reviews with network meta-analysis (NMA) *NMA Learning Live Webinar series*"

PRESENTER BIOS

 

Andrea Cipriani is Professor of Psychiatry and NIHR Research Professor at the Department of Psychiatry, University of Oxford, and Honorary Consultant Psychiatrist at Oxford Health NHS Foundation Trust. His main interest in psychiatry is evidence-based mental health and his research focuses on the evaluation of treatments in psychiatry, mainly major depression, bipolar disorder and schizophrenia. He has carried out many systematic reviews, meta-analyses and randomised controlled trials in psychopharmacology, however in the past few years he has also been investigating relevant issues in epidemiological psychiatry and public health, like patterns of drug consumption, risk of serious adverse events (most of all, suicide and deliberate self harm) and implementation of treatment guidelines. His interest in the methodology of evidence synthesis has now a specific focus on individual patient data network meta-analysis and data science, trying to assess the validity, breadth, structure and interpretation of innovative statistical and machine learning approaches to better inform the decision-making process between patients and clinicians and personalise treatment indications in routine clinical care. He has been working closely with world class academic institutions in the UK, Europe, US, Canada, Japan, China and Australia, and also with important organisations, such as the National Institute for Health and Clinical Excellence in the UK, the Istituto Superiore di Sanità in Italy, the United Nations in Vienna and the World Health Organization (WHO) in Geneva. Together with the Department of Mental Health and Substance Abuse at WHO, he has co-authored a manual on psychopharmacology, which provided evidence-based information to health care professionals in primary care especially in low- and middle-income countries. This manual is part of the Gap Action Programme of the WHO and is distributed by WHO as a reference source to assist physicians working in the primary health care through increasing their knowledge and improving their routine clinical practice in using evidence-based medicines for mental disorders. Prof Cipriani is currently the lead of the Digital/Informatics theme of the Oxford Health Biomedical Research Centre and the Editor in Chief of Evidence-Based Mental Health (https://ebmh.bmj.com/). Twitter: @And_Cipriani

Gill Norman is a research fellow at the University of Manchester and an editor, author and methodologist with Cochrane Wounds.

 

« October 2020 »
October
MoTuWeThFrSaSu
1234
567891011
12131415161718
19202122232425
262728293031
Page last updated: Aug 18, 2020
Back to top